Guri Solum
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections.
Journal: Vaccine
Published: December 16, 2025
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
Journal: The Lancet regional health. Europe
Published: August 05, 2024
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Journal: EBioMedicine
Published: January 31, 2024
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study.
Journal: The lancet. Healthy longevity
Published: December 21, 2022
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
Journal: Nature communications
Published: January 22, 2022
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy.
Journal: The Prostate
Published: July 12, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026